Pfizer-BioNTech Vaccine Appears To Work Against New Covid Variants, Study Finds, As U.S. Records Deadliest Day

  • 📰 Forbes
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

United States Headlines News

United States Latest News,United States Headlines

New research from the University of Texas and U.S. drugmaker Pfizer suggests that the company’s Covid-19 vaccine, developed with Germany’s BioNTech, is still effective against the new variants spreading rapidly, as the U.S. records its deadliest day

The latest findings do not mean the vaccine will be effective against other mutations, including the worrying E484K mutation found in the South African variant, which was not tested against.

“So we’ve now tested 16 different mutations, and none of them have really had any significant impact,” said Phil Dormitzer, one of Pfizer’s viral scientists who worked on the project.Pfizer’s paper is short, preliminary and limited in scope. It has also not been peer reviewed, which is a research process of independent evaluation to ensure accuracy and rigor.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Really? Did 3 test trials follow? They lie.

Put it in my muscle.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.